Standard BioTools Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2019 | — | $182.2M | $65.6M |
| Jun 2019 | — | $172.6M | $24.0M |
| Sep 2019 | — | $162.6M | $25.9M |
| Dec 2019 | — | $153.6M | $21.7M |
| Mar 2020 | — | $141.5M | $35.0M |
| Jun 2020 | — | $132.7M | $43.0M |
| Sep 2020 | — | $152.0M | $72.3M |
| Dec 2020 | — | $139.1M | $68.5M |
| Mar 2021 | — | $122.9M | $49.7M |
| Jun 2021 | — | $109.5M | $30.9M |
| Sep 2021 | — | $99.3M | $29.3M |
| Dec 2021 | — | $94.6M | $28.5M |
| Mar 2022 | — | $22.1M | $30.0M |
| Jun 2022 | — | $-37.5M | $74.4M |
| Sep 2022 | — | $-62.7M | $60.2M |
| Dec 2022 | $64.9M | $-81.5M | $81.3M |
| Mar 2023 | — | $-97.2M | $113.7M |
| Jun 2023 | $65.2M | $-113.4M | $142.3M |
| Sep 2023 | $64.6M | $-131.7M | $79.7M |
| Dec 2023 | $63.5M | $-148.1M | $51.7M |